Hemodynamics in HIE and acute PH

Phenotypes of "Acute PH" possibly seen in HIE

Acute PH is often implied to be a failure to relax the pulmonary vasculature in the immediate post-natal transition secondary to various cardio-pulmonary insults or stressors. This often yields to "abnormally" high PVR which may cause RV dysfunction, low pulmonary blood flow, hypoxic respiratory failure due to extra-pulmonary right to left shunting. It is often complicated by adverse cardio-pulmonary interactions, ventilation-perfusion mismatch (such as in meconium aspiration syndrome), acidosis, shock and end-organ hypoperfusion. 

Acute PH in the newborn may present with diverse cardiovascular phenotypes, each representing a unique and dynamic physiology that requires constant vigilance and customized management. Targeted Neonatal Echocardiography (TNE) can be particularly valuable in deciphering the baby's condition and guiding therapeutic interventions. It’s crucial to remember that medications bring both intended effects and potential side effects. They should be carefully titrated and discontinued as soon as they are no longer required, as prolonged use may have unintended impacts on the body and cardiovascular system.

Acute PH (Classical "PPHN") with preserved or mildly depressed cardiac function and unrestrictive ductus

These patients often have maintained RV systolic function thanks to the ductus that is "wide open" and allows to "pop-off" the right ventricle in the context of supra-systemic pulmonary vascular resistances, leading to right to left ductal shunting. The baby is blue but at least not gray as they are able to maintain perfusion, at the expense of hypoxemia. There is often low pulmonary venous return, oligemia on the chest radiography. Desaturation is of secondary to right to left atrial shunting (pre-ductal desaturation) and right to left ductal shunting (post-ductal desaturation with differential of saturations). The low pulmonary blood flow leads to decreased LA preload, which favours the right to left atrial shunt. The size of inter-atrial shunt and the relationship between RV and LV end-diastolic pressures dictates the magnitude of the atrial shunt, and the amount of hypoxic blood entering the systemic circulation at that level (making the baby more profoundly desaturated at the pre-ductal level). The wide ductus shunts away the flow from the RV output towards the systemic circulation, decreasing pulmonary blood flow. Qp < Qs, but at least systemic blood flow is maintained (better to have a blue baby than a gray baby with weak pulses and end-organ perfusion compromise). Core strategy should be to promote the fall of PVR in order to reverse the phenotype.  The pre-ductal saturations are dependent on the atrial level shunt, as well as the pulmonary venous saturations (which may be decreased if there is a component of pulmonary parenchymal disease and ventilation perfusion mismatch). 


Management:

Acute PH (Classical "PPHN") with significantly depressed cardiac function and restrictive ductus

With a closing ductus and supra-systemic pulmonary vascular resistance (PVR), the right ventricle (RV) experiences an increasing afterload that it eventually cannot overcome. The patent ductus arteriosus (PDA) is too small to equalize pressures. Consequently, the RV is forced to maintain output against high PVR, initially causing a marked rise in pulmonary arterial pressures. This elevated afterload results in RV dysfunction and adverse interactions between the RV and left ventricle (LV). These patients are at high risk of progressively impaired left atrial (LA) preload and LV output, as well as progressive drop in  which can lead to profound hypotension and poor systemic perfusion. Eventually, the RV cannot compensate and there is significant drop in RV output, increase in RV end diastolic pressure. This leads to either backflow into the systemic veins (hepatomegaly, retrograde flow in the IVC, subhepatic veins and SVC - which can raise the post-capillary pressure of the cerebral vasculature), or it can lead to increased magnitude of the shunt at the atrial level (depending on the size of the inter-atrial shunt). These patients more "blue" if the volume accross the foramen ovale increases. They become more gray if the foramen ovale is restrictive. For these patients, addressing the elevated PVR must be coupled with cardiac support and potentially re-opening the ductus.

Management:

Acute PH with a closed duct 

See the section on the premature prenatal closure of the ductus.

Management and information:

LV dysfunction

Many patients with hypoxic-ischemic encephalopathy (HIE) are at risk of left ventricular (LV) dysfunction, which is often multi-factorial in origin. Contributing factors include poor coronary perfusion, myocardial hypoxia, acidosis, electrolyte imbalances (e.g., sodium, potassium, calcium), energy substrate insufficiency (e.g., oxygen, glucose), elevated systemic vascular resistance due to vascular constriction that maintains pressure in the context of low flow, anemia (as seen in cases like fetal-maternal hemorrhage or acute bleeding such as intra-ventricular or subgaleal hemorrhages, placenta previa, or abruptio), kidney injury, adverse cardiopulmonary interactions, and inflammatory conditions (e.g., concomitant sepsis, chorioamnionitis). 

Severe LV dysfunction in these patients can lead to extremely low LV output. In such cases, the right ventricle (RV) may assume a systemic role, providing systemic blood flow, with the ductus arteriosus becoming crucial, similar to a hypoplastic left heart syndrome (HLHS) or coarctation physiology. In this context, inhaled nitric oxide (iNO) should be avoided as it may divert blood from systemic circulation. Pulmonary vasodilators can similarly increase pulmonary flow, risking flash pulmonary edema due to heightened post-capillary congestion from elevated left atrial pressure. Elevated LV end-diastolic pressures often result in a left-to-right shunt at the atrial level, with these patients typically showing "normal" pre-ductal saturations and desirable pre- and post-ductal saturation differences. The pre-ductal saturations are dependent on the atrial level shunt, as well as the pulmonary venous saturations (which may be decreased if there is a component of pulmonary parenchymal disease and ventilation perfusion mismatch). 

If the PDA is small, restrictive, or closed, severe LV dysfunction may manifest as shock with poor perfusion, weak pulses, tachycardia, mottling, prolonged capillary refill, low urine output, and marked acidosis due to impaired end-organ perfusion. Management strategies vary by severity, but significant LV dysfunction may require inotropic support (e.g., epinephrine, dobutamine) and prostaglandin E (PGE) to maintain ductal patency, thereby sustaining systemic blood flow which may depend on RV output. Milrinone should be used with caution if there is poor urinary output as it tends to renally accumulate and can cause hypotension by systemic vascular resistance drop. Milrinone takes a few hours to have effect due to its longer half-life. 

In summary, management of significant LV dysfunction involves:

- Inotropic support (e.g., epinephrine, dobutamine; occasionally milrinone) to strengthen cardiac output.

- Avoiding pulmonary vasodilators to prevent exacerbating systemic steal, especially when a right-to-left ductal shunt is essential for systemic flow.

- Maintaining ductal patency with PGE when systemic circulation relies on RV output to ensure adequate systemic blood flow.

Functional pulmonary valvular atresia/stenosis

Functional pulmonary atresia happens when the RV function is so impacted that the RVO is extremely low, and pulmonary blood flow becomes dependent on the left to right shunt at the level of the ductus. Paradoxically, these patients may have differential of saturation once the RV function improves and output becomes sufficient through the RVOT to have some bidirectional or right to left component to the ductal shunt. These patients are often quite blue with similar saturations pre-post ductal. They have significant volume of hypoxic blood entering at the atrial level (depending on the size of their foramen ovale and RV end-diastolic pressure). They may have significant hepatomegaly. These patients may benefit from PGE to provide pulmonary blood flow, which increases the LA pressure by pulmonary venous return and decreasing the atrial shunt in the Right to Left direction. They also benefit from RV inotropic support and pulmonary vasodilation if the primary cause is high PVR. Some infants with this phenotype have significant RV hypertrophy and only PGE with adequate filling (and sometimes rate control: esmolol and/or sedation-analgesia to avoid fast heart rate) may be sufficient. 

Biventricular dysfunction

In the case of significant biventricular dysfunction, the goal is to provide inotropic support. Here epinephrine and dobutamine are agents to consider. These patients are often hypotensive and hypoxic, they have low LV and RV output. Hydrocortisone may be added to provide some degree of adrenal support in certain cases. 

In all these cases, if medical management fails, one shall consider alternatives such as ECMO (and occasionally removing TH depending on the patient and the local practice).

Cardiovascular Medications

Cardiopulmonary assessment and diagnostic approach in HIE - Dr. Regan Giesinger Clinical Cardiopulmonary Physiology for the Care of the Sick Newborn Course - November 2024 

HIE_DrRGcourse-2024.pdf

Presentation - Role of TNE in HIE - World Congress of Cardiology - 2024

HIE_TNE_GALTIT_Final.pdf

© NeoCardioLab - Gabriel Altit - 2020-2025
Contact us / Contactez-nous